Technical Analysis for ATOS - Atossa Genetics Inc.

Grade Last Price % Change Price Change
grade C 4.23 -3.86% -0.17
ATOS closed down 3.86 percent on Tuesday, March 19, 2019, on 1.21 times normal volume.

Earnings due: Mar 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ATOS trend table...

Date Alert Name Type % Chg
Mar 19 1,2,3 Pullback Bullish Bullish Swing Setup 0.00%
Mar 19 Boomer Buy Setup Bullish Swing Setup 0.00%
Mar 19 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Mar 19 Calm After Storm Range Contraction 0.00%
Mar 19 Upper Bollinger Band Walk Strength 0.00%
Mar 19 Inside Day Range Contraction 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 18 Pocket Pivot Bullish Swing Setup -3.86%
Mar 18 Volume Surge Other -3.86%
Mar 18 Calm After Storm Range Contraction -3.86%

Older signals for ATOS ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company also intends to offers FullCYTE Breast Health Test, which is in development to assess the individual breast ducts for pre-cancerous changes in women; and NextCYTE Breast Cancer Test that is in the prevalidation phase to profile breast cancer specimens for prediction of treatment outcomes and distant recurrence in women newly diagnosed with breast cancer. Atossa Genetics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.
Medicine Health Cancer Healthcare Breast Cancer Diagnostic Tests Breast Implant Breast Surgery
Is ATOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.39
52 Week Low 0.35
Average Volume 3,602,362
200-Day Moving Average 1.813
50-Day Moving Average 1.6968
20-Day Moving Average 2.141
10-Day Moving Average 2.813
Average True Range 0.8167
ADX 39.22
+DI 44.0145
-DI 8.9623
Chandelier Exit (Long, 3 ATRs ) 4.9399
Chandelier Exit (Short, 3 ATRs ) 3.8101
Upper Bollinger Band 5.0646
Lower Bollinger Band -0.7826
Percent B (%b) 0.86
BandWidth 273.106025
MACD Line 0.7013
MACD Signal Line 0.3664
MACD Histogram 0.3349
Fundamentals Value
Market Cap 49.5 Million
Num Shares 11.7 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -2.17
Price-to-Sales 0.00
Price-to-Book 2.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.24
Resistance 3 (R3) 5.30 5.02 5.07
Resistance 2 (R2) 5.02 4.77 4.99 5.01
Resistance 1 (R1) 4.63 4.61 4.49 4.57 4.96
Pivot Point 4.35 4.35 4.29 4.32 4.35
Support 1 (S1) 3.96 4.10 3.82 3.90 3.50
Support 2 (S2) 3.68 3.94 3.65 3.45
Support 3 (S3) 3.29 3.68 3.39
Support 4 (S4) 3.23